RELATIONSHIP BETWEEN IRON METABOLISM, FERROPTHOSIS AND DIABETES MELLITUS
DOI:
https://doi.org/10.15547/tjs.2025.03.013Keywords:
ferroptosis, iron, ROS, diabetes mellitusAbstract
Ferroptosis is a newly discovered form of cell death, which is closely related to the high accumulation of iron ions in cells, lipid peroxidation and the presence of an imbalance between the accumulation of reactive oxygen species and antioxidants. Recently, data has begun to accumulate on the relationship between ferroptosis and numerous diseases such as cancer, Parkinson's disease, osteoarthritis, systemic lupus erythematosus, etc. Due to growing studies, ferroptosis has been found to be closely related to the appearance and development of diabetes mellitus and its complications, as well.
References
Miao, R., Fang, X., Zhang, Y. et al. Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis, 14, 186, 2023. https://doi.org/10.1038/s41419-023-05708-0
Yu, H., Guo, P., Xie, X., Wang, Y., Chen, G. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med, Apr;21(4):648-657, 2017. doi: 10.1111/jcmm.13008. Epub 2016 Nov 10. PMID: 27860262; PMCID: PMC5345622.
Toyokuni, S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci, Jan;100(1):9-16, 2009. doi: 10.1111/j.1349-7006.2008.01001.x. Epub 2008 Oct 23. PMID: 19018762; PMCID: PMC11158384.
Altamura, S., Muckenthaler, MU. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Di, 16(4):879-95, 2009. doi: 10.3233/JAD-2009-1010. PMID: 19387120.
Fargion, S., Mattioli, M., Fracanzani, AL., Sampietro, M., Tavazzi, D., Fociani, P., Taioli, E., Valenti, L., Fiorelli, G. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol, Aug;96(8):2448-55, 2001. doi: 10.1111/j.1572-0241.2001.04052.x. PMID: 11513189.
Harrison, A., Lorenzo, F., McClain, D. Iron and the Pathophysiology of Diabetes. Annu Rev Physiol, Feb 10;85:339-362, 2023. doi: 10.1146/annurev-physiol-022522-102832. Epub 2022 Sep 22. PMID: 36137277; PMCID: PMC10161568.
Ganz, T. Systemic Iron Homeostasis. Physiological Reviews, Oct;93(4):1721–1741, 2013. doi: 10.1152/physrev.00008.2013. PMID: 24137020.
Donovan, A., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature, Feb;403(6771):776–781, 2000. doi: 10.1038/35001596. PMID: 10693807.
Laurell, C. Analytical Review: What is the Function of Transferrin in Plasma? Blood, Feb;6(2):183–187, 1951. doi: 10.1182/blood.V6.2.183.183.
Horton, M. Expression of transferrin receptors during erythroid maturation. Experimental Cell Research, Apr;144(2):361–366, 1983. doi: 10.1016/0014-4827(83)90415-9. PMID: 6301865.
Frey, A., Nandal, A., Park, J., Smith, P., Yabe, T., Ryu, M., Ghosh, M., Lee, J., Rouault, T., Park, M., Philpott, C. Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase. Proc Natl Acad Sci U S A, Jun 3;111(22):8031-6, 2014. doi: 10.1073/pnas.1402732111. Epub 2014 May 19. PMID: 24843120; PMCID: PMC4050543.
Marku, A., Galli, A., Marciani, P., Dule, N., Perego, C., Castagna, M. Iron metabolism in pancreatic beta-cell function and dysfunction. Cells, 10:1–17, 2021. doi: 10.3390/cells10112841. PMID: 34831062; PMCID: PMC8616520.
Dolma, S., Lessnick, S., Hahn, W., & Stockwell, B. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell, 3, 285–296, 2003. doi: 10.1016/s1535-6108(03)00050-3. PMID: 12676586.
Yang, W., & Stockwell, B. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234–245, 2008. doi: 10.1016/j.chembiol.2008.02.010. PMID: 18355723; PMCID: PMC2683762.
Yagoda, N., et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature, 447, 864–868, 2007. https://doi.org/10.1038/nature05859
Li, J., Cao, F., Yin, Hl. et al. Ferroptosis: past, present and future. Cell Death Dis, 11, 88, 2020. https://doi.org/10.1038/s41419-020-2298-2
Dixon, S., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149, 1060–1072, 2012. doi: 10.1016/j.cell.2012.03.042. PMID: 22632970; PMCID: PMC3367386.
Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A. & Brady, N. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience, 2, 517–532, 2015. doi: 10.18632/oncoscience.160. PMID: 26097885; PMCID: PMC4468338.
Liang, C., Zhang, X., Yang, M. & Dong, X. Recent progress in ferroptosis inducers for cancer therapy. Adv. Mater. Weinh, 31, 1904197, 2019. doi: 10.1002/adma.201904197. Epub 2019 Oct 8. PMID: 31595562.
Gochenauer, G., Robinson, M. Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(-) subunits. J. Neurochem, 78 (2), 276–286, 2001. doi: 10.1046/j.1471-4159.2001.00385.x. PMID: 11461963.
Jin, E., Jo, Y., Wei, S., Rizzo, M., Ryu, D., Gariani, K. Ferroptosis and iron metabolism in diabetes: Pathogenesis, associated complications, and therapeutic implications. Front Endocrinol (Lausanne), Aug 30;15:1447148, 2024. doi: 10.3389/fendo.2024.1447148. PMID: 39279996; PMCID: PMC11392752.
Ayala, A., Muñoz, M., Argüelles, S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev, 2014:360438, 2014. doi: 10.1155/2014/360438. Epub 2014 May 8. PMID: 24999379; PMCID: PMC4066722.
Muranov, K. Fenton Reaction in vivo and in vitro. Possibilities and Limitations. Biochemistry (Mosc), Jan;89(Suppl 1):S112-S126, 2024. doi: 10.1134/S0006297924140074. PMID: 38621747.
Bruni, A., Pepper, A., Pawlick, R., Gala-Lopez, B., Gamble, A., Kin, T., et al. Ferroptosis-inducing agents compromise in vitro human islet viability and function. Cell Death Dis, 9:595, 2018. doi: 10.1038/s41419-018-0506-0
Fernandez-Real, J., McClain, D., Manco, M. Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes. Diabetes Care, 38:2169–76, 2015. doi: 10.2337/dc14-3082. PMID: 26494808.
Liu, J., Li, Q., Yang, Y., Ma, L. Iron metabolism and type 2 diabetes mellitus: A meta-analysis and systematic review. J Diabetes Investig, Jul;11(4):946-955, 2020. doi: 10.1111/jdi.13216. Epub 2020 Feb 23. PMID: 31975563; PMCID: PMC7378429.
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, Jul 15;402(10397):203-234, 2023. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22. Erratum in: Lancet. 2023 Sep 30;402(10408):1132. doi: 10.1016/S0140-6736(23)02044-5. Erratum in: Lancet. 2025 Jan 18;405(10474):202. doi: 10.1016/S0140-6736(25)00053-4. PMID: 37356446; PMCID: PMC10364581.
Díaz-López, A., Iglesias-Vázquez, L., Pallejà-Millán, M., Rey, C., Flores, G., Arija, V. Association between Iron Status and Incident Type 2 Diabetes: A Population-Based Cohort Study. Nutrients, Oct 23;12(11):3249, 2020. doi: 10.3390/nu12113249. PMID: 33114064; PMCID: PMC7690731.
Jiang, R., Manson, J., Meigs, J., Ma, J., Rifai, N., Hu, F. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA, 291:711–17, 2004. doi: 10.1001/jama.291.6.711. PMID: 14871914.
Simcox, J., McClain, D. Iron and diabetes risk. Cell Metab, 5;17(3):329-41, 2013. doi: 10.1016/j.cmet.2013.02.007. PMID: 23473030; PMCID: PMC3648340.
Beaton, M., Chakrabarti, S., Adams, P. Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease. Ann. Hepatol, May-Jun;13(3):353-6, 2014. PMID: 24756010.
Kowdley, K., Belt, P., Wilson, L., Yeh, M., Neuschwander-Tetri, B., et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology, 55:77–85, 2012. doi: 10.1002/hep.24706. Epub 2011 Dec 6. PMID: 21953442; PMCID: PMC3245347.
Nelson, J., Wilson, L., Brunt, E., Yeh, M., Kleiner, D., et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology, 53:448–57, 2011. doi: 10.1002/hep.24038. Epub 2010 Nov 29. PMID: 21274866; PMCID: PMC3058264.
Ford, E., Cogswell, M. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care, 22:1978–83, 1999. doi: 10.2337/diacare.22.12.1978. PMID: 10587829.
Fillebeen, C., Lam, N., Chow, S., Botta, A., Sweeney, G., Pantopoulos, K. Regulatory connections between iron and glucose metabolism. Int J Mol Sci, 21:1–18, 2020. doi: 10.3390/ijms21207773. PMID: 33096618; PMCID: PMC7589414.
Wei, S., Nguyen, T., Zhang, Y., Ryu, D., Gariani, K. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol (Lausanne), 14:1185221, 2023. doi: 10.3389/fendo.2023.1185221. PMID: 37455897; PMCID: PMC10344359.
Koch, R., Zoller, H., Theuri, I., Obrist, P., Egg, G., Strohmayer, W., et al. Distribution of DMT 1 within the human glandular system. Histol Histopathol, 18:1095–101, 2003. doi: 10.14670/HH-18.1095. PMID: 12973678.
Dongiovanni, P., Ruscica, M., Rametta, R., Recalcati, S., Steffani, L., Gatti, S., Girelli, D., Cairo, G., Magni, P., Fargion, S., et al. Dietary Iron Overload Induces Visceral Adipose Tissue Insulin Resistance. Am. J. Pathol, 182:2254–2263, 2013. doi: 10.1016/j.ajpath.2013.02.019. Epub 2013 Apr 8. PMID: 23578384.
Fernández-Real, J., Moreno-Navarrete, J., Ricart, W. Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance–Associated Iron Overload. Diabetes, 57:1918–1925, 2008. doi: 10.2337/db08-0041. Epub 2008 Apr 21. PMID: 18426863; PMCID: PMC2453621.
Gao, Y., Li, Z., Gabrielsen, J., Simcox, J., Lee S., Jones, D., Cooksey, B., Stoddard, G., Cefalu, W., McClain, D. Adipocyte iron regulates leptin and food intake. J. Clin. Investig, 125:3681–3691, 2015. doi: 10.1172/JCI81860. Epub 2015 Aug 24. PMID: 26301810; PMCID: PMC4588289.
Gabrielsen, J., Gao, Y., Simcox, J., Huang, J., Thorup, D., Jones, D., Cooksey, R., Gabrielsen, D., Adams, T., Hunt, S., et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Investig, 122:3529–3540, 2012. doi: 10.1172/JCI44421. Epub 2012 Sep 10. PMID: 22996660; PMCID: PMC3461897.
Robson-Doucette, C., Sultan, S., Allister, E., Wikstrom, J., Koshkin, V., Bhattacharjee, A., et al. Beta-cell uncoupling protein 2 regulates reactive oxygen species production, which influences both insulin and glucagon secretion. Diabetes, 60:2710–9, 2011. doi: 10.2337/db11-0132. Epub 2011 Oct 7. PMID: 21984579; PMCID: PMC3198081.
Santos, M., Anderson, C., Neschen, S., Zumbrennen-Bullough, K., Romney, S., Kahle-Stephan, M., et al. Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification. Nat Commun, 11:296, 2020. d doi: 10.1038/s41467-019-14004-5. PMID: 31941883; PMCID: PMC6962211.
Fleming, M., Romano, M., Su, M., Garrick, L., Garrick, M., Andrews, N. Nrumpl is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. PNAS, 95:1148–53, 1998. doi: 10.1073/pnas.95.3.1148. PMID: 9448300; PMCID: PMC18702.
Lortz, S., Tiedge, M. Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells. Free Radic. Biol. Med, 34:683–88, 2003. doi: 10.1016/s0891-5849(02)01371-0. PMID: 12633745.
Hansen, J., Tonnesen, M., Madsen, A., Hagedom, P., Friberg, J., et al. Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic (3 cell fate in response to cytokines. Cell Metab, 16:449–61, 2012. doi: 10.1016/j.cmet.2012.09.001. Epub 2012 Sep 20. PMID: 23000401.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
